NAGE: Niagen Bioscience, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-29 | New 13G stake | BlackRock, Inc. | 5.20% | SEC |
Institutional ownership (Q2 2026)
139 institutions reported holding $95.12M of Niagen Bioscience, Inc. on Form 13F (143 the quarter before). 23 opened a new position and 26 sold out. Shares held by institutions: -13%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 4,184,659 | $13.35M |
| SteelPeak Wealth, LLC | 3,500,129 | $11.17M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,147,018 | $6.85M |
| Qube Research & Technologies Ltd | 1,625,016 | $5.18M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,478,603 | $4.72M |
| UBS Group AG | 1,283,296 | $4.09M |
| GOLDMAN SACHS GROUP INC | 1,262,743 | $4.03M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,171,215 | $3.74M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,166,233 | $3.72M |
| STATE STREET CORP | 1,082,752 | $3.45M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.